Table 3.
Methods | (%) | HD (mm) | Images | Eval method | Trim-95% | Year |
---|---|---|---|---|---|---|
Zhu10 UR-Net | 93.61 | 80 | Train:76, test:4 | Yes | 2018 | |
He27 BT + CNN-ASM | Promise-12 | Train:50, test:30 | Yes | 2017 | ||
Jecevicius28 AAM | 93 | 4.12 | Promise-12 | 50-fold, leave-one-out | Yes | 2017 |
Meyer9 3D-CNN | 92.10 | Prostate- | Train: 25, test: 15 | Yes | 2018 | |
Yu7 U + Res net | 89.43 | 5.54 | Promise-12 | Train: 50, test: 30 | Yes | 2017 |
Jia11 ensemble | Promise-12 | Fourfold cross validation | Yes | 2018 | ||
Our HNNsc | 145 (NIH) | Fivefold cross validation | No | 2018 | ||
Our HNNsc | Promise-12 | Train: 50, test: 30 | Yes | 2018 |